Home » Galapagos Initiates Phase II Trial for Multiple Sclerosis
Galapagos Initiates Phase II Trial for Multiple Sclerosis
Galapagos NV announced that it has started a Phase II clinical study to evaluate Nanocort’s effectiveness in treating flares in multiple sclerosis.
CNNMoney
CNNMoney
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May